Skip to content
Review

Role of probiotics in neonatal care: From molecular mechanisms to clinical practice.

Oct 2026 · Clinical Nutrition ESPEN · pp. 105215 · 0 citations
Medicine

Abstract

Premature births remain a significant global health concern, contributing to high mortality rates among children under five. Preterm newborns (<37 weeks' gestation) encounter considerable health issues due to their underdeveloped organ systems and gut microbiota. These vulnerabilities result in major complications, including necrotizing enterocolitis, sepsis, and feeding intolerance, leading to higher rates of morbidity and mortality, particularly in very preterm infants. In this context, probiotic supplementation has emerged as a widely studied intervention to restore gut homeostasis. This review summarises the therapeutic potential of probiotic strains of the Lactobacillus, Bifidobacterium, and Saccharomyces genera, along with their distinct molecular mechanisms of action, including competitive pathogen exclusion, reinforcement of the intestinal epithelial barrier, and immunomodulation. However, despite promising evidence, a critical research-to-practice gap exists due to concerns regarding the safety, strain specificity, dosage and the lack of standardized dosing guidelines. Furthermore, administration of live microbial strains to critically ill neonates carry inherent safety risks. This review aims to provide a thorough and even-handed approach on the role of probiotics in preventing preterm complications and evaluate the evolving global safety guidelines, emphasizing the urgent need for standardized, strain-specific clinical protocols to ensure their safe and effective integration in neonatal intensive care.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.